Augoff Katarzyna, Rabczynski Jerzy, Tabola Renata, Czapla Leszek, Ratajczak Katarzyna, Grabowski Krzysztof
Department of Gastrointestinal and General Surgery, Wrocław Medical University, Wrocław, Poland.
Med Sci Monit. 2008 Oct;14(10):CR530-5.
Recent studies showed that a small leucine-rich proteoglycan, decorin, may suppress tumor progression as a natural anticancer agent negatively controlling cellular growth. It was hypothesized that physiological expression of decorin may be associated with cellular senescence of the colorectal mucosa and that its down-regulation, promoting an increase in cellular proliferation, could participate in the progression of adenoma to adenocarcinoma. Therefore the expression of decorin in hyperplastic and neoplastic polyps of the colorectum was examined and compared with normal colonic mucosa and colon cancer tissues.
MATERIAL/METHODS: Tissue samples were obtained from 41 patients with different types of colonic polyps (6 hyperplastic adenomas, 34 neoplastic adenomas, and 1 adenomatous polyp with focal carcinoma) and 12 patients with colon cancer. Seven samples of normal colon tissue were used as controls. Paraffin-embedded samples were used for immunohistochemical study.
Normal and hyperplastic tissues and the majority of tubular adenomas showed strong expression of decorin in the stroma. Adenomas with a villous component showed moderate and very low decorin immunoreactivity. The decrease in decorin reactivity in tubulo-villous adenomas was significant as compared with other polyps and controls. Weak decorin immunoreactivity in stroma adjacent to clusters of cancerous cells was also found in most cases of common types of adenocarcinoma, but not in adenocarcinoma mucinosum.
The expression of decorin may be involved in the differentiation of colonic polyps and reduced expression of decorin may abrogate the defensive potential of stromal tissue and promote the development of common types of colon carcinoma.
最近的研究表明,一种富含亮氨酸的小分子蛋白聚糖——核心蛋白聚糖,可能作为一种天然抗癌剂抑制肿瘤进展,对细胞生长起到负调控作用。据推测,核心蛋白聚糖的生理表达可能与结直肠黏膜的细胞衰老有关,其下调会促进细胞增殖增加,可能参与腺瘤向腺癌的进展。因此,研究并比较了核心蛋白聚糖在结直肠增生性和肿瘤性息肉中的表达情况,并与正常结肠黏膜和结肠癌组织进行对比。
材料/方法:从41例不同类型结肠息肉患者(6例增生性腺瘤、34例肿瘤性腺瘤和1例伴有局灶癌的腺瘤性息肉)以及12例结肠癌患者中获取组织样本。7份正常结肠组织样本用作对照。石蜡包埋样本用于免疫组织化学研究。
正常组织、增生性组织以及大多数管状腺瘤在基质中显示出核心蛋白聚糖的强表达。具有绒毛成分的腺瘤显示出中等和极低的核心蛋白聚糖免疫反应性。与其他息肉和对照相比,管状绒毛状腺瘤中核心蛋白聚糖反应性的降低具有显著性。在大多数常见类型腺癌病例中,也发现癌细胞簇相邻基质中核心蛋白聚糖免疫反应性较弱,但黏液腺癌中未发现。
核心蛋白聚糖的表达可能参与结肠息肉的分化,核心蛋白聚糖表达降低可能消除基质组织的防御潜能,促进常见类型结肠癌的发展。